In carrying out the federal covid-19 “test-to-treat” initiative, California is targeting the uninsured by outfitting 138 testing sites with screenings for free antiviral drugs. But as of mid-June, fewer than 800 people had been prescribed the medicines. And two-thirds of those undergoing screenings are insured.
Noble Health swept into two small Missouri towns promising to save their hospitals. Instead, workers and vendors say it stopped paying bills and government inspectors found it put patients at risk. Within two years — after taking millions in federal covid relief and big administrative fees — it locked the doors.
The Biden administration’s latest plan to address opioid overdose deaths includes $30 million for harm reduction measures, but many conservative states don’t allow them.
In early 2022, Illinois joined a growing number of states where lawmakers and school leaders are trying to combat the ongoing student mental health crisis by granting days off for mental health needs.
Physicians have long believed it’s good medicine to consider race in health care. But recently, rather than perpetuate the myth that race governs how bodies function, a more nuanced approach has emerged: acknowledging that racial health disparities often reflect the effects of generations of systemic racism, such as lack of access to stable housing or nutritious food.
People in jail who have serious mental illness and cannot stand trial because of their condition are waiting months, or even more than a year, to get into their state psychiatric hospitals.
The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.
State Sen. Scott Wiener opens up about a weeklong stint in the hospital last year and what it’s like to live with Crohn’s disease. The San Francisco Democrat is pushing a bill that would require insurance companies to cover certain medications while patients appeal denials.
Residents of a Butte neighborhood are concerned about the dust from a nearby open-pit mine that can coat their homes and vehicles. In a city where past mining left a legacy of soil and water pollution, is the air unsafe, too?
Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.
